AI-Driven Dual-Function RNA Therapeutics for HBV, Alzheimer's and Cancer
Livera is developing a dual-function RNA therapeutics platform designed to reduce disease-driving antigen or protein burden while activating immune-mediated clearance, with an initial focus on chronic hepatitis B, Alzheimer’s disease, and solid tumors.
Advancing Innovation in Drug Discovery
Our platform integrates AI-assisted target discovery, rational siRNA/mRNA design, and immune-modulating therapeutic strategies to develop next-generation medicines for HBV, Alzheimer's disease, and Cancer.
Leadership
Board of Directors
Investors
Leadership Team
Li Ke
CEO
View More
Xincan Qiu
CSO
Yuhang Wang
VP of Chemistry
View More
Yizhong Wang
Head of Drug Delivery
View More
Renhai Huang
Head of AI Platform
View More
Xiaolin Gan
Business Lead
View More
Xiaoting Tang
Clinical Lead
View More